Aortech Share Discussion Threads

[the stigologist] 15/1/2018 13:15

I wouldn't even bother trying to put an upside capping number on it yet until they reveal their strategic plan but the sense I get is hundreds of millions not mere tens

[mikeh30] 15/1/2018 13:05

If they can Re-negotiate some of their existing licenses and add new licensees with higher % fees we could easily be looking at a 10-20m Mcap.There is obvious value here, now the litigation is over and cash position improving, it's time to see if they can exploit their new found free time and expertise.Literally, my money is on them succeeding. I'm expecting, at any time, a strategic review with news of new licensees and renegotiated fees. 100p to start.Aimho dyor etc ...

[cocker] 12/1/2018 17:06

I have a feeling Roy's a jock, in which case he is more than capable of tossing his own cabor.

[the stigologist] 12/1/2018 16:12

Were you two together last night then ?

[cocker] 12/1/2018 15:59

Probably a fair point Roy

[spawny100] 12/1/2018 13:39

AOR/MYN almost identical chart pattern of late. Which will breakout first?

[semper vigilans] 12/1/2018 11:03

Depends who it’s with!

[mikeh30] 11/1/2018 11:01

Buy the dips

[bbr391] 10/1/2018 17:39

Could be well above £1 .
Given great news .
On average news about £1 seems fair dinkum.

Best of Luck All

[parsons4] 10/1/2018 14:55

I agree mikeh30

[mikeh30] 10/1/2018 14:10

Rather flush out the stale holders on a nothing day so when we get a decent RNS it won't be sold into immediately. This rose by 150% on a single day recently so we know what it can do. Buy and hold. Massive rewards

[parsons4] 10/1/2018 14:01

I could only get another 5k this morning at 48p but as soon as there was a 50p bid the sellers came out. the 26812,24000 and 3 lots of 10000 were all sales It is no wonder that some long term holders want to get out as soon as the price approaches the recent highs. Of course this has enabled me and others to build up a decent holding as the story here is very exciting at a 5 to 10 times your money possibility.
GLA

[babbler] 10/1/2018 12:52

If you can...

[mikeh30] 10/1/2018 12:44

Chart is building nicely. Buy the dips

[babbler] 10/1/2018 12:42

Ah the games ...

[cocker] 10/1/2018 12:20

50k of shares showing as sells when in fact buys

[mikeh30] 10/1/2018 11:00

Wow.10 bagger news right there if they can realise the value

[the stigologist] 10/1/2018 10:53

And this from a 2011 RNS shows the sort of value potential there is...

Co- Development Project - $32 million
In July 2007, we announced a licensing and supply agreement for the evaluation of Elast-Eon™ by a global device company. This agreement allowed the licensee to acquire certain AorTech intellectual property rights and encompassed potential milestone payments of up to $32 million. The Agreement between AorTech and the licensee has recently been terminated by mutual consent with AorTech re-acquiring all of its Patents and it's Intellectual Property at the end of the notice period on 1 March 2012. Your Board believes that it is in the long term interests of the Company and its shareholders to take ownership of this Intellectual Property which is one of the key drivers to creating shareholder value. Later in this report I will explain the Group's strategy to benefit fully from the value of AorTech's Intellectual Property.

St Jude Medical - Pacing Leads
Shareholders may well be aware of the success St Jude Medical ('SJM') is achieving in the Cardiac Rhythm Management market by having converted the insulation of all of their pacing products to Elast-Eon™ (re-branded by St Jude as Optim™). A recent Credit Suisse note on SJM (8 November 2011) increased the target valuation of St Jude by $1.6 billion due to the success of the durability performance of Optim™ insulated leads. We view this development as very positive as it demonstrates to not only the medical device industry but also the financial markets the value that can be added to a medical device by utilising AorTech's Elast-Eon™ material, and this provides a significant marketing opportunity for us.

[mikeh30] 10/1/2018 10:41

A detailed strategic plan to allow AorTech to commercialise its platform technology is currently being considered and we will report to shareholders when the process is concluded.Won't be long

[babbler] 10/1/2018 10:16

Slowly...don't want p and d ...

[mikeh30] 10/1/2018 10:04

Through 60p today